Vimarsana
Biggest News Aggregation in the World

Page 2 - C Diff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from C Diff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In C Diff Today - Breaking & Trending Today

Experts' Perspectives: AGA Recommends FMT for C Diff - Vimarsana News

Experts' Perspectives: AGA Recommends FMT for C Diff

Investigators from the guideline panel discuss the AGA’s recommendations regarding the use of fecal microbiota-based therapies for CDI, IBD, and IBS.

Omadacycline Shows Promise as Safe, Effective C Diff Antibiotic Compared to Vancomycin - Vimarsana News

Omadacycline Shows Promise as Safe, Effective C Diff Antibiotic Compared to Vancomycin

Participants given omadacycline had high fecal concentrations with a distinct microbiome profile compared to those in the vancomycin group, with study results calling attention to the importance of antibiotics’ impact on the gut microbiome.

Pure Science: Bleach Study's Author Discusses Research on Eliminating C difficile on Soft Surfaces - Vimarsana News

Pure Science: Bleach Study's Author Discusses Research on Eliminating C difficile on Soft Surfaces

After pushback on social media, Tina Joshi, PhD, spoke with Infection Control Today to clarify and explain her study, her lifelong research, and what she hopes IPs and other IPC personnel can take from them.

Contaminated beds linked to C. diff risks: Study - Vimarsana News

Contaminated beds linked to C. diff risks: Study

New research published in Infection Control & Hospital Epidemiology reveals that patients staying in a hospital bed previously occupied by someone with a Clostr

C Difficile Vaccine Shows Lot Consistency, Induces Toxin A and B Antibody Responses - Vimarsana News

C Difficile Vaccine Shows Lot Consistency, Induces Toxin A and B Antibody Responses

Data from the phase 3 study confirmed the lot consistency, immunogenicity, safety, and tolerability of a toxoid-based Clostridioides difficile vaccine.

Source: ajmc.com